Mirvie

Exciting news - Mirvie has won the MedTech Breakthrough award for Best Overall Women’s Health Solution! 🎉 At Mirvie, we’re pioneering a new approach to understand the biology of pregnancy by leveraging #RNA to predict life-threatening complications months in advance. We’re thrilled to be recognized as a leader in women’s health and pregnancy health as we double down on innovation tackling the #maternalhealth crisis. 

ICYMI: Mirvie’s Maneesh Jain and General Catalyst’s Holly Maloney shed light on the full scope of the maternal health crisis and why we need all hands on deck to solve it. Read more in Fortune on this urgent call for action to create healthier futures for moms and babies: https://lnkd.in/gShafZPP

While Preeclampsia Awareness Month has come to a close, it’s critical to continue shining a light on the stories of preeclampsia survivors and highlight how prediction and prevention of #preeclampsia is possible. With technology soon available to provide objective risk data on preeclampsia, early awareness makes effective prevention possible. Visit PreeclampsiaPrevention.com to access our free toolkit for both pregnant patients and #physicians, including a discussion guide on preeclampsia when speaking with care teams and evidence-based strategies that can be incorporated into daily routines to prevent preeclampsia, including taking baby aspirin, monitoring blood pressure at-home, and more. And a special shout out to organizations like Preeclampsia Foundation and Endpreeclampsia.org who keep a spotlight on this life-threatening complication all year.

ICYMI: Read more from TODAY.com about preeclampsia survivor Lindsay Orr’s harrowing experience as her seemingly routine pregnancy transformed into a crisis because of the life-threatening complication. A test like Mirvie’s could be a crucial tool for pregnant patients to understand their personalized risk of developing preeclampsia so they can do everything in their power to prevent it. https://hubs.li/Q02yKRFj0 #PreventionIsPossible #Preeclampsia #PregnancyHealth

Lindsay’s experience is what drives our work at Mirvie. Nobody should have to go through the trauma she endured. In an ideal scenario, Lindsay would have known her risk of preeclampsia months before experiencing symptoms. This would have given her a window to work closely with her care team to put a preventive action plan in place and stay vigilant for signs and symptoms if it did occur. Her story is a heart-wrenching reminder of the urgency of our work because all mothers deserve the healthiest pregnancies possible. Read more about Lindsay’s story and perspectives from Dallas Reed, MD, FACMG, FACOG Reed and Michal Elovitz on what preeclampsia is and how dangerous it can be for pregnant patients and their babies, as well as innovation on the horizon to shift pregnancy health from reactive to proactive at TODAY.com. And thank you to Preeclampsia Foundation for shining a light on stories like Lindsay’s.

Reflecting on #ACOG2024, there was an unmatched enthusiasm around Mirvie’s RNA Platform, engagement with our clinician toolkit, and demand for preeclampsia prediction and prevention strategies! We spoke with more than 1,250 attendees to learn about how they'll soon be able to use our test to help them make #preeclampsia prevention possible for more patients. Thank you to everyone who visited our new booth and learned more about what we’re doing to shape the future of #pregnancy health! It was loud and clear that providers want a test and action plan for preeclampsia prevention. What was your top highlight from American College of Obstetricians and Gynecologists (ACOG) this year?

As we’re about to kick off American College of Obstetricians and Gynecologists (ACOG)'s annual conference, I could not be more proud of our Mirvie team. We launched an important education campaign, “Preeclampsia Prevention is Possible” during Preeclampsia Awareness Month. We’re ready to meet thousands of clinicians and providers within #maternalhealth in San Francisco this weekend to highlight there are evidence-based strategies pregnant patients can use to reduce their risk of #preeclampsia. The Mirvie #RNA Platform is a breakthrough for predicting preeclampsia months in advance. It is clear that there is significant demand among pregnant women for preeclampsia prediction and prevention. With prediction technology on the horizon, pregnant patients and their care teams can take action to prevent complications like preeclampsia. Learn more about how we’re shaping the future of pregnancy health by visiting us at booth #326. Discover our landmark research, clinical progress, and clinician toolkit! #ACOG2024

Pregnancy health is often shrouded in mystery due to lack of research and resources. That's why it's essential to drive evidence-based research and seek innovative solutions to make every pregnancy as safe and healthy as possible. In their latest Fortune op-ed, GC's Holly Maloney and Mirvie's CEO and co-founder, Maneesh Jain illuminate the opportunity to shift from reactive to proactive pregnancy care. Learn more ↓

As we reflect on Mother’s Day, it’s important to consider how each of us may contribute to solving the #maternalhealth crisis. Every maternal mortality is a heartbreaking tragedy. What’s shocking is that for every mother who dies during pregnancy or childbirth, more than 100 women face near-death experiences because of life-threatening pregnancy complications. It’s unacceptable that as we live in the 21st century surrounded by medical breakthroughs, pregnancy and childbirth today can still be so dangerous. Currently, we lack effective tools to predict who will develop life-threatening complications in pregnancy. For example, #preeclampsia - a leading cause of maternal mortality and morbidity - was officially recognized as a life-threatening complication more than 100 years ago. However, in over a century, there’s been a failure to uncover the why (underlying biology) and who’s at risk. At Mirvie, we’ve heard countless stories of how rapidly pregnancy complications can transform seemingly routine pregnancies into crises in a matter of days or even hours. We’re excited that innovation like Mirvie’s test is finally on the horizon to objectively predict who's at highest risk for developing pregnancy complications like preeclampsia. We’re at the threshold of shifting pregnancy care from reactive to proactive. However, the speed of progress and number of breakthroughs would greatly increase if more researchers, investors, scientists, and executives across the board took an active role in trying to reverse the rising tide of the maternal health crisis. Read more in Fortune where Holly Maloney of General Catalyst and I highlight how collective action is needed to initiate a transformative shift that maternal health so desperately needs to create a world where every pregnancy is as healthy and as safe as possible.